Overview
Uvera is developing a natural UV protective ingredient that is safe for human health and environmentally friendly, targeting the full spectrum of UV sun radiation. The company focuses on using biotechnology to create alternatives to harmful chemical sunscreens that can damage coral reefs and human health.
Financials
Revenue history (in k)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 77 days late). All were audited by a statutory auditor.
- 2025filed
- 202404/07/2025
- 202327/06/2024
- 202215/07/2023
- 202130/09/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Sun protection ingredient
- UV filter
- Cyanobacteria biomass
Websites
- uvera.euSafe and eco-friendly UV skin protectionGoogle Tag ManagerApache
Job offers
The company has its own careers page: uvera.eu.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, each member of the management board acting independently is authorized to make declarations of will on behalf of the company and represent the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-12-22.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $349,180.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 5, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $23,352$23,352 | PREZYDENT MIASTA GDYNIA | |
| Dec 5, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $14,689$14,689 | PREZYDENT MIASTA GDYNIA | |
| Dec 5, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $12,658$12,658 | PREZYDENT MIASTA GDYNIA |
European Funds
2 projects recorded: 1 from FE lists ($71,814) and 1 Commission grant (FTS) ($2,841,585).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-10-01 | Safe and natural uv skin protection | $2.8M$2,841,585 | 1.1.31 - Horizon 2020 | |
| 2020-05-16 | Preparation of a Eurogrant application planned to be submitted by UVera S.A. under the EIC Accelerator call | $71,814$71,814 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Scope Fluidics S.A. | $1,264,188.85 | scopefluidics.com | ||
| Centrum Innowacji I Wdrożeń Bio-Inwest sp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Nanogroup S.A. | $843,099.47 | nanogroup.eu | ||
| Bioceltix S.A. | $616,315.97 | bioceltix.com | ||
| Pharmena S.A. | $541,436.46 | pharmena.eu | ||
| VET Cell Tech sp. z o.o. | $483,439.81 | vetcelltech.com | ||
| Vaxican sp. z o.o. | $390,933.79 | vaxican.com | ||
| Protexture sp. z o.o. | $339,354.50 | protexture.pl | ||
| Bioactive-Tech sp. z o.o. | $228,068.15 | bioactivetech.pl | ||
| Bactrem sp. z o.o. | $181,958.36 | bactrem.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-01-14 | Share capital increase (162,265.00 PLN → 180,850.00 PLN) | |
| 2020-09-29 | Share capital increase (141,100.00 PLN → 162,265.00 PLN) | |
| 2018-12-12 | Entered in the register |
FAQ
Last updated: 2026-03-29
